Please wait while the formulary information is being retrieved.
Drug overview for HICON (sodium iodide-131):
Generic name: SODIUM IODIDE-131
Drug class:
Therapeutic class: Antineoplastics
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
Generic name: SODIUM IODIDE-131
Drug class:
Therapeutic class: Antineoplastics
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
DRUG IMAGES
No Image Available
The following indications for HICON (sodium iodide-131) have been approved by the FDA:
Indications:
Hyperthyroidism
Thyroid carcinoma
Professional Synonyms:
Malignant epithelial neoplasm of thyroid
Malignant epithelial tumor of thyroid
Indications:
Hyperthyroidism
Thyroid carcinoma
Professional Synonyms:
Malignant epithelial neoplasm of thyroid
Malignant epithelial tumor of thyroid
The following dosing information is available for HICON (sodium iodide-131):
No enhanced Dosing information available for this drug.
No enhanced Administration information available for this drug.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for HICON (sodium iodide-131):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for HICON (sodium iodide-131):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 2 contraindications.
Absolute contraindication.
| Contraindication List |
|---|
| Lactation |
| Pregnancy |
There are 1 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
| Severe List |
|---|
| Kidney disease with reduction in glomerular filtration rate (GFr) |
There are 1 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| Dehydration |
The following adverse reaction information is available for HICON (sodium iodide-131):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 20 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Hyperthyroidism Hypothyroidism Nasolacrimal duct stenosis Radiation sickness Thyrotoxicosis crisis |
Bone marrow depression |
| Rare/Very Rare |
|---|
|
Anaphylaxis Anemia Cerebral edema Hypoparathyroidism Infertility Leukemia Leukopenia Malignancy Oligospermia Pulmonary fibrosis Radiation pneumonitis Secondary ovarian failure Thrombocytopenic disorder Thyroiditis |
There are 21 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Pharyngeal edema Sialoadenitis |
Chest pain Dry eye Eye tearing Injection site sequelae Nausea Pruritus of skin Skin rash Tachycardia Urticaria Vomiting |
| Rare/Very Rare |
|---|
|
Conjunctivitis Cough Dacryocystitis Fever Headache disorder Iododerma Neck pain Sore throat Xerostomia |
The following precautions are available for HICON (sodium iodide-131):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for HICON (sodium iodide-131):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for HICON (sodium iodide-131)'s list of indications:
| Hyperthyroidism | |
| E05 | Thyrotoxicosis [hyperthyroidism] |
| E05.0 | Thyrotoxicosis with diffuse goiter |
| E05.00 | Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm |
| E05.01 | Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm |
| E05.1 | Thyrotoxicosis with toxic single thyroid nodule |
| E05.10 | Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm |
| E05.11 | Thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm |
| E05.2 | Thyrotoxicosis with toxic multinodular goiter |
| E05.20 | Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm |
| E05.21 | Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis or storm |
| E05.3 | Thyrotoxicosis from ectopic thyroid tissue |
| E05.30 | Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm |
| E05.31 | Thyrotoxicosis from ectopic thyroid tissue with thyrotoxic crisis or storm |
| E05.4 | Thyrotoxicosis factitia |
| E05.40 | Thyrotoxicosis factitia without thyrotoxic crisis or storm |
| E05.41 | Thyrotoxicosis factitia with thyrotoxic crisis or storm |
| E05.8 | Other thyrotoxicosis |
| E05.80 | Other thyrotoxicosis without thyrotoxic crisis or storm |
| E05.81 | Other thyrotoxicosis with thyrotoxic crisis or storm |
| E05.9 | Thyrotoxicosis, unspecified |
| E05.90 | Thyrotoxicosis, unspecified without thyrotoxic crisis or storm |
| E05.91 | Thyrotoxicosis, unspecified with thyrotoxic crisis or storm |
| Thyroid carcinoma | |
| C73 | Malignant neoplasm of thyroid gland |
Formulary Reference Tool